Jazz Pharmaceuticals plc XNAS: JAZZ

Mid-range Performer

Download real time

132.95 1.79 (1.36%)

39.23% Gain from 52W Low

1.0M

XNAS Volume

XNAS 10 Nov, 2025 3:39 PM (EST)

Jazz Pharmaceuticals plc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents